LOGM 2017 Annual Report

Years Ended December 31, 2013 2014 2015 2016 2017 (In thousands) Cost of revenue: Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . $ 706 $ 1,107 $ 1,560 $ 2,289 $ 5,222 Intangible amortization . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1,820 3,959 4,151 6,382 57,216 Research and development: Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . 3,761 3,653 5,188 6,201 22,103 Sales and marketing: Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . 7,242 9,033 11,090 16,181 16,155 General and administrative: Stock-based compensation . . . . . . . . . . . . . . . . . . . . . . . . . . 8,005 10,976 8,661 13,679 23,812 As of December 31, 2013 2014 2015 2016 2017 (In thousands) Consolidated Balance Sheet Data: Cash and cash equivalents and short-term marketable securities . . . . . . . . . . . . . . . . . . . . . $189,556 $201,169 $208,427 $196,466 $ 252,402 Total assets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 279,613 317,849 455,699 443,293 3,858,108 Deferred revenue, including long-term portion . . 85,163 105,250 136,989 162,253 347,305 Long-term debt . . . . . . . . . . . . . . . . . . . . . . . . . . . — — 60,000 30,000 — Total liabilities . . . . . . . . . . . . . . . . . . . . . . . . . . . 112,274 144,005 247,888 247,177 694,367 Total equity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167,339 173,844 207,811 196,116 3,163,741 33